Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Wednesday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of NYSE AMPE opened at $0.00 on Wednesday. The stock has a market capitalization of $2,394.00, a P/E ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $2.47. The business has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.01.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.